載入...
Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy
Y-320, a novel immune-modulator, inhibits IL-17 production by CD4(+) T cells stimulated with IL-15. Its use in autoimmune diseases such as rheumatoid arthritis has been documented. However, no studies have be conducted to evaluate its application in cancer treatment either as mono or combined therap...
Na minha lista:
| 發表在: | Am J Transl Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
e-Century Publishing Corporation
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7061851/ https://ncbi.nlm.nih.gov/pubmed/32194903 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|